• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

Germline mutations in hereditary diffuse gastric cancer

摘要Gastric cancer is one of the leading causes of cancer-related deaths worldwide.Among which,about 1%-3% of gastric cancer patients were characterized by inherited gastric cancer predisposition syndromes,knowing as hereditary diffuse gastric cancer (HDGC).Studies reported that CDH1 germline mutations are the main cause of HDGC.With the help of rapid development of genetic testing technologies and data analysis tools,more and more researchers focus on seeking candidate susceptibility genes for hereditary cancer syndromes.In addition,National Comprehensive Cancer Network (NCCN) guidelines recommend that the patients of HDGC carrying CDH1 mutations should undergo prophylactic gastrectomy or routine endoscopic surveillances.Therefore,genetic counseling plays a key role in helping individuals with pathogenic mutations make appropriate risk management plans.Moreover,experienced and professional genetic counselors as well as a systematic multidisciplinary team (MDT) are also required to facilitate the development of genetic counseling and benefit pathogenic mutation carriers who are in need of regular and standardized risk management solutions.In this review,we provided an overview about the germline mutations of several genes identified in HDGC,suggesting that these genes may potentially act as susceptibility genes for this malignant cancer syndrome.Furthermore,we introduced information for prevention,diagnosis and risk management of HDGC.Investigations on key factors that may have effect on risk management decision-making and genetic data collection of more cancer syndrome family pedigrees are required for the development of HDGC therapeutic strategies.

更多
广告
作者单位 Surgery Laboratory, the Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010050, China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing), Department of Molecular Diagnostics, Peking University Cancer Hospital & Institute,Beijing 100142, China [1] Department of Gynecology, Weifang Maternal and Child Health Hospital, Weifang 261011, China [2] Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing), Department of Molecular Diagnostics, Peking University Cancer Hospital & Institute,Beijing 100142, China [3] Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing), Center of Gastrointestinal Surgery, Peking University Cancer Hospital &Institute, Beijing 100142, China [4]
栏目名称 Review Article
DOI 10.21147/j.issn.1000-9604.2018.01.13
发布时间 2018-05-30
基金项目
Beijing Municipal Administration of Hospitals' Youth Program Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support Inner Mongolia Science & Technology Plan
提交
  • 浏览27
  • 下载14
中国癌症研究(英文版)

中国癌症研究(英文版)

2018年30卷1期

122-130页

SCIMEDLINEISTICCSCDCA

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷